Announcements Trials
Browse Landscape

Status

Withdrawn 1Unknown 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Gastrointestinal 2Classical hematology 1Breast 1

Conditions

Breast Neoplasms 4Pancreatic Neoplasms 2Uterine Cervical Neoplasms 1Thyroid Cancer, Papillary 1Myasthenia Gravis 1Kidney Neoplasms 1Hereditary Breast and Ovarian Cancer Syndrome 1Glioblastoma 1Fanconi Anemia, Complementation Group D1 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Intraductal, Noninfiltrating 1Breast Diseases 1Breast Carcinoma In Situ 1

Interventions

Gemcitabine 683130-nm albumin-bound paclitaxel 198Fluorouracil 188Oxaliplatin 175Albumin-Bound Paclitaxel 154Capecitabine 137Leucovorin 131Irinotecan 112Radiotherapy 96Taxes 85pembrolizumab 81Cisplatin 72Erlotinib Hydrochloride 70Radiosurgery 69Nivolumab 56Drug Therapy 56Bevacizumab 54Magnetic Resonance Spectroscopy 50Cyclophosphamide 49folfirinox 45Specimen Handling 42Docetaxel 42Cetuximab 40irinotecan sucrosofate 38Biopsy 38S 1 (combination) 36Pancreaticoduodenectomy 35Blood Specimen Collection 34Surgical Procedures, Operative 31Paclitaxel 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Pancreatic Neoplasms × Genotype × Clear all
NCT05329597 2022-04-15

Study on Umorestat Hydrogen Sulfate Capsule in Patients With Locally Advanced/Metastatic Pancreatic Cancer

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Unknown
88 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT00580021 2016-01-28

Clinical Outcomes in Hereditary Cancer

Memorial Sloan Kettering Cancer Center

Withdrawn
BreastClassical hematologyGastrointestinal

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡